Press release
The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030, predicts Roots Analysis
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programsRoots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:
A detailed assessment of the current market landscape of companies offering drug repurposing services.
Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.
An analysis of the partnerships that have been established in this domain, in the recent past.
An analysis of the initiatives of big biopharma players engaged in this domain.
A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.
A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of Repurposing Approaches
Disease-centric approach
Target-centric approach
Drug-centric approach
Therapeutic Area
Same Therapeutic Area
Different Therapeutic Area
Type of Drug Molecule
Biologics
Small Molecule
Key Geographical Region
North America
Europe
Asia-Pacific
For more information please click on the following link:
https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
Key companies covered in the report
Auxillis Pharma
ChemBio Discovery Solutions
Excelra
GVK Bio
Iris Pharma
Lantern Pharma
PanXome
Pharmacelera
Physiogenex
Smart Pharma
Socium
SOM Biotech
For more information please click on the following link:
https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
Other Recent Offerings
1. Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030
2. China Biopharmaceutical Contract Manufacturing Market, 2020-2030
3. Antibody Contract Manufacturing Market, 2020 - 2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030, predicts Roots Analysis here
News-ID: 2180840 • Views: …
More Releases from Roots Analysis
ADC Contract Manufacturing Market Set to Soar, Reaching USD 6.8 Billion by 2035
In the fast-evolving world of biopharmaceuticals, the demand for precision and innovation has never been higher. Nowhere is this more evident than in the rapidly expanding market for Antibody-Drug Conjugate (ADC) contract manufacturing. According to a comprehensive new report from Roots Analysis, the global ADC contract manufacturing market is poised for remarkable growth-projected to surge from USD 1.79 billion in 2024 to over USD 6.8 billion by 2035, at a…
Big Gains Ahead: Microbiome Manufacturing Set to Transform Medicine by 2035
Imagine a world where a simple pouch of specially prepared bacteria could reset your gut health, helping you recover from chronic illness or even prevent disease before it starts. That world is closer than you think. According to a new report from Roots Analysis, the global microbiome manufacturing market-once a niche corner of biotech-is poised for explosive growth, with projections soaring from $27 million in 2023 to over $185 million…
Global Insulin Pumps Market Set to Surge, Driven by Innovation and Patient Deman …
Imagine waking up every day knowing that managing your diabetes means multiple injections, constant monitoring, and a lifestyle that often feels dictated by your condition. For millions around the world, this is a daily reality. But thanks to rapid advancements in medical technology, a new era is dawning-one where insulin pumps are transforming lives, offering convenience, precision, and a newfound sense of freedom.
To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/insulin-pump-market/request-quote.html
A…
Autoinjectors Market CAGR to Exceed 6.2% by 2035, Due To The Growing Demand For …
According to our latest market report "Global Autoinjectors Market" by Usability, Route of Administration, Type of Molecule Delivered, Type of Actuation Mechanism, Volume of Container, End User, Target Indication and Key Geographical Regions: Industry Trends and Global Forecasts, till 2035", the global autoinjectors market size is projected to reach around USD 176 billion by 2035 from USD 96.2 billion, growing at a CAGR of 6.2% in the forecast period 2024-2035.…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
